nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRM1—telencephalic ventricle—malignant glioma	0.0543	0.299	CbGeAlD
Remifentanil—Cerebral infarction—Carmustine—malignant glioma	0.0449	0.0642	CcSEcCtD
Remifentanil—Cerebral ischaemia—Temozolomide—malignant glioma	0.0293	0.0418	CcSEcCtD
Remifentanil—Lymphopenia—Temozolomide—malignant glioma	0.0277	0.0395	CcSEcCtD
Remifentanil—OPRD1—telencephalon—malignant glioma	0.0191	0.105	CbGeAlD
Remifentanil—Coagulopathy—Temozolomide—malignant glioma	0.0182	0.026	CcSEcCtD
Remifentanil—Leukocytosis—Carmustine—malignant glioma	0.0156	0.0223	CcSEcCtD
Remifentanil—OPRM1—brainstem—malignant glioma	0.0147	0.081	CbGeAlD
Remifentanil—Urinary incontinence—Carmustine—malignant glioma	0.0141	0.0202	CcSEcCtD
Remifentanil—Urinary incontinence—Temozolomide—malignant glioma	0.0137	0.0195	CcSEcCtD
Remifentanil—OPRM1—telencephalon—malignant glioma	0.013	0.0719	CbGeAlD
Remifentanil—Amnesia—Carmustine—malignant glioma	0.0113	0.0162	CcSEcCtD
Remifentanil—Nasal congestion—Temozolomide—malignant glioma	0.0113	0.0161	CcSEcCtD
Remifentanil—Pethidine—CYP2B6—malignant glioma	0.011	0.54	CrCbGaD
Remifentanil—Amnesia—Temozolomide—malignant glioma	0.0109	0.0156	CcSEcCtD
Remifentanil—OPRD1—central nervous system—malignant glioma	0.0109	0.0599	CbGeAlD
Remifentanil—OPRK1—central nervous system—malignant glioma	0.0104	0.0575	CbGeAlD
Remifentanil—OPRK1—cerebellum—malignant glioma	0.0102	0.0562	CbGeAlD
Remifentanil—Hypokalaemia—Carmustine—malignant glioma	0.00968	0.0138	CcSEcCtD
Remifentanil—Pethidine—SLC6A3—malignant glioma	0.00937	0.46	CrCbGaD
Remifentanil—OPRM1—midbrain—malignant glioma	0.00937	0.0516	CbGeAlD
Remifentanil—Hypokalaemia—Temozolomide—malignant glioma	0.00935	0.0133	CcSEcCtD
Remifentanil—Dysphagia—Carmustine—malignant glioma	0.00919	0.0131	CcSEcCtD
Remifentanil—OPRM1—spinal cord—malignant glioma	0.00914	0.0504	CbGeAlD
Remifentanil—Dysphagia—Temozolomide—malignant glioma	0.00888	0.0127	CcSEcCtD
Remifentanil—OPRD1—brain—malignant glioma	0.00863	0.0476	CbGeAlD
Remifentanil—Bronchitis—Temozolomide—malignant glioma	0.00854	0.0122	CcSEcCtD
Remifentanil—Dysuria—Temozolomide—malignant glioma	0.00831	0.0119	CcSEcCtD
Remifentanil—Hyperglycaemia—Carmustine—malignant glioma	0.00829	0.0118	CcSEcCtD
Remifentanil—OPRK1—brain—malignant glioma	0.00828	0.0456	CbGeAlD
Remifentanil—Pneumonia—Carmustine—malignant glioma	0.00824	0.0118	CcSEcCtD
Remifentanil—Renal failure—Carmustine—malignant glioma	0.00806	0.0115	CcSEcCtD
Remifentanil—Hyperglycaemia—Temozolomide—malignant glioma	0.00801	0.0114	CcSEcCtD
Remifentanil—Pneumonia—Temozolomide—malignant glioma	0.00797	0.0114	CcSEcCtD
Remifentanil—OPRM1—central nervous system—malignant glioma	0.00742	0.0409	CbGeAlD
Remifentanil—Haemoglobin—Carmustine—malignant glioma	0.00739	0.0106	CcSEcCtD
Remifentanil—Haemorrhage—Carmustine—malignant glioma	0.00736	0.0105	CcSEcCtD
Remifentanil—Hallucination—Carmustine—malignant glioma	0.00732	0.0104	CcSEcCtD
Remifentanil—Haemoglobin—Temozolomide—malignant glioma	0.00715	0.0102	CcSEcCtD
Remifentanil—Haemorrhage—Temozolomide—malignant glioma	0.00711	0.0101	CcSEcCtD
Remifentanil—Visual impairment—Carmustine—malignant glioma	0.00709	0.0101	CcSEcCtD
Remifentanil—Hallucination—Temozolomide—malignant glioma	0.00707	0.0101	CcSEcCtD
Remifentanil—Pharyngitis—Temozolomide—malignant glioma	0.00706	0.0101	CcSEcCtD
Remifentanil—Visual impairment—Temozolomide—malignant glioma	0.00685	0.00978	CcSEcCtD
Remifentanil—Flushing—Carmustine—malignant glioma	0.00683	0.00975	CcSEcCtD
Remifentanil—Cardiac disorder—Temozolomide—malignant glioma	0.0066	0.00942	CcSEcCtD
Remifentanil—Flushing—Temozolomide—malignant glioma	0.0066	0.00942	CcSEcCtD
Remifentanil—Arrhythmia—Carmustine—malignant glioma	0.00657	0.00938	CcSEcCtD
Remifentanil—Angiopathy—Temozolomide—malignant glioma	0.00645	0.00921	CcSEcCtD
Remifentanil—Immune system disorder—Temozolomide—malignant glioma	0.00642	0.00917	CcSEcCtD
Remifentanil—Mediastinal disorder—Temozolomide—malignant glioma	0.00641	0.00915	CcSEcCtD
Remifentanil—Erythema—Carmustine—malignant glioma	0.0064	0.00914	CcSEcCtD
Remifentanil—Chills—Temozolomide—malignant glioma	0.00638	0.00911	CcSEcCtD
Remifentanil—Erythema—Temozolomide—malignant glioma	0.00619	0.00883	CcSEcCtD
Remifentanil—Tremor—Carmustine—malignant glioma	0.006	0.00856	CcSEcCtD
Remifentanil—Anaemia—Carmustine—malignant glioma	0.00592	0.00845	CcSEcCtD
Remifentanil—OPRM1—brain—malignant glioma	0.00589	0.0325	CbGeAlD
Remifentanil—Agitation—Carmustine—malignant glioma	0.00589	0.0084	CcSEcCtD
Remifentanil—Tremor—Temozolomide—malignant glioma	0.0058	0.00828	CcSEcCtD
Remifentanil—Anaemia—Temozolomide—malignant glioma	0.00572	0.00816	CcSEcCtD
Remifentanil—Agitation—Temozolomide—malignant glioma	0.00569	0.00812	CcSEcCtD
Remifentanil—Convulsion—Carmustine—malignant glioma	0.00555	0.00792	CcSEcCtD
Remifentanil—Hypertension—Carmustine—malignant glioma	0.00553	0.00789	CcSEcCtD
Remifentanil—Anxiety—Carmustine—malignant glioma	0.00543	0.00776	CcSEcCtD
Remifentanil—Cough—Temozolomide—malignant glioma	0.0054	0.00771	CcSEcCtD
Remifentanil—Convulsion—Temozolomide—malignant glioma	0.00536	0.00765	CcSEcCtD
Remifentanil—Hypertension—Temozolomide—malignant glioma	0.00534	0.00763	CcSEcCtD
Remifentanil—Confusional state—Carmustine—malignant glioma	0.00527	0.00752	CcSEcCtD
Remifentanil—Anxiety—Temozolomide—malignant glioma	0.00525	0.00749	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00523	0.00747	CcSEcCtD
Remifentanil—Oedema—Carmustine—malignant glioma	0.00523	0.00746	CcSEcCtD
Remifentanil—Dry mouth—Temozolomide—malignant glioma	0.00515	0.00736	CcSEcCtD
Remifentanil—Thrombocytopenia—Carmustine—malignant glioma	0.00512	0.0073	CcSEcCtD
Remifentanil—Tachycardia—Carmustine—malignant glioma	0.0051	0.00728	CcSEcCtD
Remifentanil—Confusional state—Temozolomide—malignant glioma	0.00509	0.00727	CcSEcCtD
Remifentanil—Anaphylactic shock—Temozolomide—malignant glioma	0.00505	0.00721	CcSEcCtD
Remifentanil—Oedema—Temozolomide—malignant glioma	0.00505	0.00721	CcSEcCtD
Remifentanil—Nervous system disorder—Temozolomide—malignant glioma	0.00495	0.00707	CcSEcCtD
Remifentanil—Thrombocytopenia—Temozolomide—malignant glioma	0.00495	0.00706	CcSEcCtD
Remifentanil—Skin disorder—Temozolomide—malignant glioma	0.00491	0.007	CcSEcCtD
Remifentanil—Hypotension—Carmustine—malignant glioma	0.00488	0.00697	CcSEcCtD
Remifentanil—Hyperhidrosis—Temozolomide—malignant glioma	0.00488	0.00697	CcSEcCtD
Remifentanil—Paraesthesia—Carmustine—malignant glioma	0.00469	0.0067	CcSEcCtD
Remifentanil—Dyspnoea—Carmustine—malignant glioma	0.00466	0.00665	CcSEcCtD
Remifentanil—Somnolence—Carmustine—malignant glioma	0.00465	0.00663	CcSEcCtD
Remifentanil—Paraesthesia—Temozolomide—malignant glioma	0.00454	0.00647	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Carmustine—malignant glioma	0.00451	0.00644	CcSEcCtD
Remifentanil—Dyspnoea—Temozolomide—malignant glioma	0.0045	0.00643	CcSEcCtD
Remifentanil—Somnolence—Temozolomide—malignant glioma	0.00449	0.00641	CcSEcCtD
Remifentanil—Constipation—Carmustine—malignant glioma	0.00447	0.00638	CcSEcCtD
Remifentanil—Pain—Carmustine—malignant glioma	0.00447	0.00638	CcSEcCtD
Remifentanil—Dyspepsia—Temozolomide—malignant glioma	0.00445	0.00635	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00436	0.00622	CcSEcCtD
Remifentanil—Pain—Temozolomide—malignant glioma	0.00432	0.00617	CcSEcCtD
Remifentanil—Constipation—Temozolomide—malignant glioma	0.00432	0.00617	CcSEcCtD
Remifentanil—Feeling abnormal—Carmustine—malignant glioma	0.00431	0.00615	CcSEcCtD
Remifentanil—Feeling abnormal—Temozolomide—malignant glioma	0.00416	0.00594	CcSEcCtD
Remifentanil—Body temperature increased—Carmustine—malignant glioma	0.00413	0.0059	CcSEcCtD
Remifentanil—Urticaria—Temozolomide—malignant glioma	0.00401	0.00573	CcSEcCtD
Remifentanil—Body temperature increased—Temozolomide—malignant glioma	0.00399	0.0057	CcSEcCtD
Remifentanil—Hypersensitivity—Carmustine—malignant glioma	0.00385	0.0055	CcSEcCtD
Remifentanil—Hypersensitivity—Temozolomide—malignant glioma	0.00372	0.00531	CcSEcCtD
Remifentanil—Diarrhoea—Carmustine—malignant glioma	0.00358	0.0051	CcSEcCtD
Remifentanil—Pruritus—Temozolomide—malignant glioma	0.00357	0.0051	CcSEcCtD
Remifentanil—Dizziness—Carmustine—malignant glioma	0.00346	0.00493	CcSEcCtD
Remifentanil—Diarrhoea—Temozolomide—malignant glioma	0.00346	0.00493	CcSEcCtD
Remifentanil—Dizziness—Temozolomide—malignant glioma	0.00334	0.00477	CcSEcCtD
Remifentanil—Vomiting—Carmustine—malignant glioma	0.00332	0.00474	CcSEcCtD
Remifentanil—Rash—Carmustine—malignant glioma	0.0033	0.0047	CcSEcCtD
Remifentanil—Dermatitis—Carmustine—malignant glioma	0.00329	0.0047	CcSEcCtD
Remifentanil—Headache—Carmustine—malignant glioma	0.00327	0.00467	CcSEcCtD
Remifentanil—Vomiting—Temozolomide—malignant glioma	0.00321	0.00458	CcSEcCtD
Remifentanil—Rash—Temozolomide—malignant glioma	0.00318	0.00455	CcSEcCtD
Remifentanil—Dermatitis—Temozolomide—malignant glioma	0.00318	0.00454	CcSEcCtD
Remifentanil—Headache—Temozolomide—malignant glioma	0.00316	0.00452	CcSEcCtD
Remifentanil—Nausea—Carmustine—malignant glioma	0.0031	0.00443	CcSEcCtD
Remifentanil—Nausea—Temozolomide—malignant glioma	0.003	0.00428	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—BDKRB2—malignant glioma	0.000151	0.00155	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIST1H3B—malignant glioma	0.000151	0.00155	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—malignant glioma	0.000145	0.00148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MMP3—malignant glioma	0.000144	0.00148	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SUFU—malignant glioma	0.000144	0.00147	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HEY2—malignant glioma	0.000142	0.00146	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GFAP—malignant glioma	0.000139	0.00142	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAG2—malignant glioma	0.000138	0.00141	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KNG1—malignant glioma	0.000138	0.00141	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPHK1—malignant glioma	0.000134	0.00138	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—H3F3A—malignant glioma	0.000133	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—F2—malignant glioma	0.000132	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR3—malignant glioma	0.000132	0.00135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HEY1—malignant glioma	0.000132	0.00135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR4—malignant glioma	0.000132	0.00135	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—YWHAE—malignant glioma	0.000128	0.00132	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NTRK2—malignant glioma	0.000128	0.00132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIST1H3B—malignant glioma	0.000128	0.00131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FLT1—malignant glioma	0.000128	0.00131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DUSP6—malignant glioma	0.000127	0.0013	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000127	0.0013	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAG1—malignant glioma	0.000126	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH3—malignant glioma	0.000125	0.00128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FBXW7—malignant glioma	0.000123	0.00126	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—malignant glioma	0.000122	0.00125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MMP3—malignant glioma	0.000122	0.00125	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BDKRB2—malignant glioma	0.000121	0.00124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—F2—malignant glioma	0.00012	0.00123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—H3F3A—malignant glioma	0.000117	0.0012	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAG2—malignant glioma	0.000117	0.0012	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—F2—malignant glioma	0.000116	0.00119	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT2—malignant glioma	0.000116	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR3—malignant glioma	0.000116	0.00119	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CG—malignant glioma	0.000115	0.00118	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PTPN11—malignant glioma	0.000113	0.00116	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—YWHAE—malignant glioma	0.000113	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NTRK2—malignant glioma	0.000113	0.00115	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH2—malignant glioma	0.000112	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FLT1—malignant glioma	0.000112	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DUSP6—malignant glioma	0.000112	0.00114	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000111	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000111	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAG1—malignant glioma	0.00011	0.00113	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KNG1—malignant glioma	0.00011	0.00112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH3—malignant glioma	0.00011	0.00112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FBXW7—malignant glioma	0.000108	0.00111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BDKRB2—malignant glioma	0.000106	0.00108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—F2—malignant glioma	0.000105	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT2—malignant glioma	0.000105	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NTRK1—malignant glioma	0.000105	0.00107	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT2—malignant glioma	0.000102	0.00104	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CD—malignant glioma	0.000101	0.00104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CG—malignant glioma	0.000101	0.00103	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PTPN11—malignant glioma	9.9e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—H3F3A—malignant glioma	9.87e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH2—malignant glioma	9.84e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—F2—malignant glioma	9.8e-05	0.001	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR3—malignant glioma	9.78e-05	0.001	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CD—malignant glioma	9.76e-05	0.001	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP3—malignant glioma	9.72e-05	0.000997	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CB—malignant glioma	9.7e-05	0.000994	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN2B—malignant glioma	9.64e-05	0.000988	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KNG1—malignant glioma	9.62e-05	0.000986	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NTRK2—malignant glioma	9.51e-05	0.000975	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—YWHAE—malignant glioma	9.51e-05	0.000975	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FLT1—malignant glioma	9.47e-05	0.00097	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DUSP6—malignant glioma	9.43e-05	0.000966	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CG—malignant glioma	9.38e-05	0.000961	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTK2—malignant glioma	9.36e-05	0.000959	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—malignant glioma	9.32e-05	0.000955	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAG1—malignant glioma	9.31e-05	0.000954	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH3—malignant glioma	9.27e-05	0.00095	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT2—malignant glioma	9.22e-05	0.000945	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HES1—malignant glioma	9.2e-05	0.000942	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NTRK1—malignant glioma	9.17e-05	0.00094	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NCOR1—malignant glioma	9.14e-05	0.000937	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FBXW7—malignant glioma	9.12e-05	0.000934	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RAF1—malignant glioma	9.02e-05	0.000924	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BDKRB2—malignant glioma	8.94e-05	0.000916	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—malignant glioma	8.91e-05	0.000913	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—F2—malignant glioma	8.9e-05	0.000912	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CD—malignant glioma	8.86e-05	0.000908	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—malignant glioma	8.81e-05	0.000902	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFRA—malignant glioma	8.76e-05	0.000897	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT2—malignant glioma	8.58e-05	0.000879	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP3—malignant glioma	8.53e-05	0.000874	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—malignant glioma	8.52e-05	0.000873	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—malignant glioma	8.5e-05	0.000871	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SPP1—malignant glioma	8.5e-05	0.000871	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—malignant glioma	8.46e-05	0.000867	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN2B—malignant glioma	8.45e-05	0.000866	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTPN11—malignant glioma	8.37e-05	0.000858	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH2—malignant glioma	8.31e-05	0.000852	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—malignant glioma	8.25e-05	0.000845	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTK2—malignant glioma	8.21e-05	0.000841	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—malignant glioma	8.17e-05	0.000837	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KNG1—malignant glioma	8.13e-05	0.000834	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—malignant glioma	8.09e-05	0.000829	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HES1—malignant glioma	8.06e-05	0.000826	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TERT—malignant glioma	8.06e-05	0.000826	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NCOR1—malignant glioma	8.02e-05	0.000822	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RAF1—malignant glioma	7.91e-05	0.000811	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFB—malignant glioma	7.87e-05	0.000806	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGFR1—malignant glioma	7.82e-05	0.000802	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—malignant glioma	7.81e-05	0.0008	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT2—malignant glioma	7.79e-05	0.000799	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NTRK1—malignant glioma	7.75e-05	0.000794	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—malignant glioma	7.72e-05	0.000791	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—malignant glioma	7.71e-05	0.00079	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFRA—malignant glioma	7.68e-05	0.000787	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—malignant glioma	7.49e-05	0.000767	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CAV1—malignant glioma	7.45e-05	0.000764	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SPP1—malignant glioma	7.45e-05	0.000764	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—malignant glioma	7.42e-05	0.00076	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—malignant glioma	7.37e-05	0.000755	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP3—malignant glioma	7.21e-05	0.000739	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	7.19e-05	0.000737	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	7.14e-05	0.000732	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FN1—malignant glioma	7.09e-05	0.000727	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—F2—malignant glioma	7.09e-05	0.000727	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—malignant glioma	7.09e-05	0.000727	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TERT—malignant glioma	7.07e-05	0.000724	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BAD—malignant glioma	7.01e-05	0.000718	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH1—malignant glioma	6.94e-05	0.000711	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTK2—malignant glioma	6.94e-05	0.000711	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	6.91e-05	0.000708	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFB—malignant glioma	6.9e-05	0.000707	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGFR1—malignant glioma	6.86e-05	0.000703	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HES1—malignant glioma	6.82e-05	0.000698	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD80—malignant glioma	6.8e-05	0.000697	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APC—malignant glioma	6.79e-05	0.000696	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—malignant glioma	6.79e-05	0.000696	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NCOR1—malignant glioma	6.78e-05	0.000694	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—malignant glioma	6.76e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGF—malignant glioma	6.71e-05	0.000688	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAF1—malignant glioma	6.68e-05	0.000685	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTPN11—malignant glioma	6.67e-05	0.000684	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—malignant glioma	6.6e-05	0.000676	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CAV1—malignant glioma	6.54e-05	0.00067	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.53e-05	0.000669	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	6.49e-05	0.000665	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—malignant glioma	6.46e-05	0.000662	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BRAF—malignant glioma	6.38e-05	0.000654	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPP1—malignant glioma	6.3e-05	0.000646	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	6.27e-05	0.000643	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FN1—malignant glioma	6.22e-05	0.000638	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—F2—malignant glioma	6.22e-05	0.000638	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT2—malignant glioma	6.21e-05	0.000637	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—malignant glioma	6.19e-05	0.000634	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BAD—malignant glioma	6.15e-05	0.00063	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	6.09e-05	0.000624	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—malignant glioma	5.99e-05	0.000614	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TERT—malignant glioma	5.97e-05	0.000612	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—malignant glioma	5.97e-05	0.000612	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD80—malignant glioma	5.96e-05	0.000611	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	5.95e-05	0.00061	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APC—malignant glioma	5.95e-05	0.00061	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—malignant glioma	5.91e-05	0.000606	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGF—malignant glioma	5.88e-05	0.000603	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTPN11—malignant glioma	5.85e-05	0.000599	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—malignant glioma	5.84e-05	0.000599	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFB—malignant glioma	5.83e-05	0.000597	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGFR1—malignant glioma	5.8e-05	0.000594	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF2—malignant glioma	5.71e-05	0.000586	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—malignant glioma	5.71e-05	0.000585	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BRAF—malignant glioma	5.6e-05	0.000573	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CAV1—malignant glioma	5.52e-05	0.000566	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—malignant glioma	5.46e-05	0.00056	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT2—malignant glioma	5.45e-05	0.000558	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—malignant glioma	5.42e-05	0.000556	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	5.37e-05	0.00055	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MDM2—malignant glioma	5.35e-05	0.000548	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAF1—malignant glioma	5.33e-05	0.000546	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB2—malignant glioma	5.27e-05	0.00054	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2—malignant glioma	5.26e-05	0.000539	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FN1—malignant glioma	5.26e-05	0.000539	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	5.23e-05	0.000536	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	5.2e-05	0.000533	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BAD—malignant glioma	5.2e-05	0.000532	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	5.18e-05	0.000531	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	5.15e-05	0.000527	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—malignant glioma	5.12e-05	0.000525	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD80—malignant glioma	5.04e-05	0.000517	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APC—malignant glioma	5.03e-05	0.000516	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	5.03e-05	0.000516	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF2—malignant glioma	5.01e-05	0.000514	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—malignant glioma	5e-05	0.000512	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGF—malignant glioma	4.97e-05	0.00051	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTPN11—malignant glioma	4.94e-05	0.000507	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	4.83e-05	0.000495	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—malignant glioma	4.78e-05	0.00049	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—malignant glioma	4.78e-05	0.00049	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BRAF—malignant glioma	4.73e-05	0.000485	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	4.71e-05	0.000482	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MDM2—malignant glioma	4.69e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAF1—malignant glioma	4.67e-05	0.000479	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB2—malignant glioma	4.62e-05	0.000474	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT2—malignant glioma	4.6e-05	0.000472	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—malignant glioma	4.58e-05	0.00047	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	4.56e-05	0.000467	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—malignant glioma	4.52e-05	0.000463	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTEN—malignant glioma	4.5e-05	0.000461	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	4.42e-05	0.000453	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—malignant glioma	4.39e-05	0.000449	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—malignant glioma	4.38e-05	0.000449	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.38e-05	0.000449	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—malignant glioma	4.33e-05	0.000444	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF2—malignant glioma	4.24e-05	0.000434	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	4.23e-05	0.000434	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—malignant glioma	4.2e-05	0.00043	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—malignant glioma	4.19e-05	0.000429	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—malignant glioma	4.06e-05	0.000416	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—malignant glioma	4.02e-05	0.000412	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.98e-05	0.000408	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—malignant glioma	3.97e-05	0.000406	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MDM2—malignant glioma	3.96e-05	0.000406	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAF1—malignant glioma	3.95e-05	0.000405	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTEN—malignant glioma	3.94e-05	0.000404	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB2—malignant glioma	3.91e-05	0.0004	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	3.86e-05	0.000395	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—malignant glioma	3.85e-05	0.000394	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—malignant glioma	3.74e-05	0.000383	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—malignant glioma	3.7e-05	0.00038	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—malignant glioma	3.65e-05	0.000374	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	3.58e-05	0.000367	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—malignant glioma	3.56e-05	0.000365	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—malignant glioma	3.55e-05	0.000363	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—malignant glioma	3.54e-05	0.000363	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—malignant glioma	3.53e-05	0.000361	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—malignant glioma	3.45e-05	0.000354	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—malignant glioma	3.35e-05	0.000343	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTEN—malignant glioma	3.33e-05	0.000341	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—malignant glioma	3.28e-05	0.000336	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—malignant glioma	3.25e-05	0.000333	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—malignant glioma	3.2e-05	0.000328	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	3.17e-05	0.000325	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—malignant glioma	3.07e-05	0.000314	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—malignant glioma	3.03e-05	0.00031	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—malignant glioma	3.01e-05	0.000308	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—malignant glioma	2.98e-05	0.000305	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	2.78e-05	0.000285	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—malignant glioma	2.77e-05	0.000284	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—malignant glioma	2.71e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—malignant glioma	2.69e-05	0.000276	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—malignant glioma	2.59e-05	0.000265	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—malignant glioma	2.56e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	2.35e-05	0.000241	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—malignant glioma	2.27e-05	0.000233	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—malignant glioma	2.27e-05	0.000233	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—malignant glioma	1.92e-05	0.000197	CbGpPWpGaD
